
Sign up to save your podcasts
Or


Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
By JAMA Network3.8
1111 ratings
Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

319 Listeners

503 Listeners

40 Listeners

163 Listeners

59 Listeners

113,458 Listeners

38 Listeners

56,968 Listeners

21 Listeners

15 Listeners

7 Listeners

17 Listeners

19 Listeners

5 Listeners

6 Listeners

47 Listeners

30 Listeners

10 Listeners

90 Listeners

14 Listeners

5 Listeners

5 Listeners

106 Listeners

18 Listeners

15,584 Listeners

2 Listeners

1,209 Listeners